Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025IMC-M113V was well ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

On the first full day of the conference, reports from the first HIV cure trial conducted in Africa, the RIO trial and others showed that perhaps, a broadly useful cure is on the horizon.

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

its functional cure candidate for human immunodeficiency virus (HIV). The data, presented in an oral session at the Conference on Retroviruses and Opportunistic Infections (CROI) 2025, in San ...

A small French biotech is trumpeting results from a trial suggesting its developmental drug could be used as part of an HIV cure. The phase 2a trial of AbiVax’s ABX464 pill is small but confirms ...

By targeting infected cells in the brain, drug may clear virus ... Proof-of-Concept Study to Find Functional Cure for HIV July 24, 2024 — Researchers conducted a breakthrough proof-of-concept ...

US biotech Excision BioTherapeutics has raised $60 million to test a potential HIV cure in the clinic, which would use CRISPR technology to snip out the viral code from human cells and tissues.

Send it to Jessica and Rich here. It’s anonymous! Dear How to Do It, My partner of 10 years tested positive for HIV two years into our relationship. I’ve continued to test negative, ...

Gilead (GILD) Sciences presented the first data from its ongoing Phase 1 study investigating two novel, once-yearly formulations of lenacapavir, the company’s injectable HIV-1 capsid inhibitor ...